Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

The Beauty Health Co. (SKIN)

The Beauty Health Co. (SKIN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BeautyHealth (NASDAQ:SKIN) Beats Q1 Sales Targets But Quarterly Guidance Underwhelms

BeautyHealth (NASDAQ:SKIN) Beats Q1 Sales Targets But Quarterly Guidance Underwhelms

SKIN : 2.74 (-1.08%)
BeautyHealth (SKIN) Reports Earnings Tomorrow: What To Expect

BeautyHealth (SKIN) Reports Earnings Tomorrow: What To Expect

SKIN : 2.74 (-1.08%)
COTY : 10.66 (-2.91%)
IPAR : 124.50 (-0.65%)
Aggressive Investors: Take a Gander At These 2 Penny Stocks’ Unusually Active Options

On Thursday, 68 unusually active options with stocks below $5 were traded. Penny stocks aren’t for the faint of heart. However, if you’re a risk-tolerant investor, two options look investment-worthy....

SKIN : 2.74 (-1.08%)
SIRI : 3.01 (-1.31%)
SPOT : 302.82 (+1.58%)
BRK.B : 416.94 (+0.92%)
LSXMA : 24.34 (-1.18%)
LSXMK : 24.32 (-0.98%)
Q4 Rundown: BeautyHealth (NASDAQ:SKIN) Vs Other Personal Care Stocks

Q4 Rundown: BeautyHealth (NASDAQ:SKIN) Vs Other Personal Care Stocks

SKIN : 2.74 (-1.08%)
HNST : 2.90 (-3.01%)
MED : 25.00 (-1.42%)
COTY : 10.66 (-2.91%)
ELF : 158.45 (-2.35%)
S&P Futures Climb Ahead of Key U.S. PPI and Retail Sales Data, Adobe Earnings on Tap

March S&P 500 E-Mini futures (ESH24) are trending up +0.37% this morning as market participants geared up for crucial U.S. PPI and retail sales data while also awaiting quarterly results from software...

ESH24 : 5,101.67s (-1.01%)
DLTR : 117.31 (-3.29%)
TSLA : 177.46 (+1.50%)
INTC : 31.83 (-0.62%)
SKIN : 2.74 (-1.08%)
ADBE : 483.43 (+0.11%)
DG : 142.13 (-3.04%)
ULTA : 399.56 (-0.37%)
DKS : 194.54 (-1.21%)
ECV.D.DX : 17.010 (+0.35%)
SDF.D.DX : 13.680 (+2.40%)
S : 21.89 (-1.26%)
BeautyHealth (SKIN) Shares Skyrocket, What You Need To Know

BeautyHealth (SKIN) Shares Skyrocket, What You Need To Know

SKIN : 2.74 (-1.08%)
Stock Index Futures Muted After Post-CPI Rally, U.S. PPI and Retail Sales Data Awaited

March S&P 500 E-Mini futures (ESH24) are down -0.02%, and March Nasdaq 100 E-Mini futures (NQH24) are down -0.11% this morning after three major U.S. benchmark indices ended the regular session higher...

ESH24 : 5,101.67s (-1.01%)
NQH24 : 17,854.75s (-0.94%)
ORCL : 123.50 (+1.10%)
MMM : 105.26 (+0.38%)
IBM : 169.03 (+0.04%)
LUV : 27.86 (-0.43%)
LEN : 165.88 (+0.41%)
DLTR : 117.31 (-3.29%)
WSM : 309.50 (-1.14%)
ZAL.D.DX : 24.370 (+0.25%)
EOAN.D.DX : 12.712 (+0.09%)
BNP.P.DX : 72.860 (+0.76%)
BeautyHealth (NASDAQ:SKIN) Beats Q4 Sales Targets, Stock Jumps 19.6%

BeautyHealth (NASDAQ:SKIN) Beats Q4 Sales Targets, Stock Jumps 19.6%

SKIN : 2.74 (-1.08%)
BeautyHealth (SKIN) Q4 Earnings: What To Expect

BeautyHealth (SKIN) Q4 Earnings: What To Expect

SKIN : 2.74 (-1.08%)
IPAR : 124.50 (-0.65%)
EPC : 40.38 (-0.10%)
Winners And Losers Of Q3: BeautyHealth (NASDAQ:SKIN) Vs The Rest Of The Personal Care Stocks

Winners And Losers Of Q3: BeautyHealth (NASDAQ:SKIN) Vs The Rest Of The Personal Care Stocks

SKIN : 2.74 (-1.08%)
OLPX : 1.6200 (-1.82%)
NUS : 13.65 (-1.52%)
IPAR : 124.50 (-0.65%)
USNA : 48.99 (+0.97%)

Barchart Exclusives

Down 20% from Highs, Should You Buy the Dip in Palantir Stock?
Amid a nearly 21% pullback from its early March highs, investors might be contemplating whether to seize the opportunity to buy Palantir stock, especially as it now aligns more closely with analysts' mean price target following post-earnings declines. Let’s have a closer look. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar